Axona Offers Symptomatic Relief In Alzheimer’s Patients

Posted by Axona on January 20th, 2020

The neurodegenerative disease Alzheimer’s is, perhaps, the single largest cause for dementia or loss of memory. Also because of the absence of curative treatment, this mental illness has a huge global impact and presence. Thus there are numerous efforts made towards finding some way to either cure it or modify it in a way that it causes the least harm.

Many different approaches have been taken; some in alternative medicines, some offering symptomatic relief and others guaranteeing supportive treatment. However, a definite cure is yet to be found. But there have been several instances wherein medical foods, like Axona, have been successful in providing symptomatic benefits. In fact, Axona studies reveal that administration of Axona helps the neurons get an alternative energy source in the form of ketone bodies.

What are medical foods

This special category of food is manufactured taking into account certain important disease-specific dietary requirements. Thus any chronic condition which has a distinctive nutritional requirement can benefit from the supervised administration of medical foods like Axona.

However, medical foods never claim to replace prescription medicines that need to be taken to keep the medical condition under control. In fact, they should be taken along with the prescribed medicines after discussing it out with the concerned physician.

It is, however, a fact that Axona reviews that have been conducted also point to the success the administration of this medical food has been able to achieve in the management of the symptoms of mild to moderate Alzheimer’s patients.

Axona composition and effects

Axona, a proprietary food from Ceresin, comprises of a unique combination of caprylic acid that is supposed to target those metabolic deficiencies which are associated with Alzheimer’s. This neurodegenerative illness is characterised by cerebral hypometabolism; a direct result of the reduction in cerebral perfusion. Conditions which cause this reduction are vascular risk factors like degeneration of the brain capillaries and ageing. Due to this degeneration, the optimal energy substrate delivery to the neural tissues get affected and both neural stability and metabolism rates subside. The result is evident in the cognitive decline commonly suffered in Alzheimer’s and also leads to:

• Synaptic loss,
• The formation of senile plaques,
• Tissue atrophy,
• Neurofibrillary tangles and
• Also neuro-degeneration.

Axona studies have shown Axona to be a medium-chain triglyceride composed mainly of caprylic acid and glycerine. In the liver, this medium-chain triglyceride gets converted into a ketone body namely beta-hydroxybutyrate or BHB which is the alternate source of energy supplied to the neurons to compensate for the reduced supply of energy substrates. Since BHB is easily able to cross the barrier between the brain and blood, it can conveniently reach the mitochondria present in the neurons where it leads to the formation of ATP. This helps to facilitate improved symptom management in patients suffering from Alzheimer’s and also brings them relief.

It has been found in most Axona reviews that it works efficiently when taken orally. It comes in powder form and needs to be taken once in a day in the form of a mixture made either using water or some other fluid. This mixture should be taken immediately after it has been made.